Kamel Chettab

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Dendritic Cells

Magnetic Resonance

Top Venues

Molecular pharmaceutics

Cancer immunology research

Centre Léon Bérard

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Centre Léon Bérard Apr 01 2007

France

Project leader :: Immunity, virus, inflammation

Publications

Iseulys Richert, Paul Berchard, Lhorra Abbes, Alexey Novikov, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jerome Kerzerho, Martine Caroff, Jean Yves Blay, Aurélie Dutour
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages. Cancers 15 (18) (2023)
Kamel Chettab, Eva-Laure Matera, Maxime Lafond, Durieux Coralie, Camille Favin-Lévêque, Clémence Goy, Regina Strakhova, Jean-Louis Mestas, Cyril Lafon, Charles Dumontet
Proof of Concept: Protein Delivery into Human Erythrocytes Using Stable Cavitation. Molecular pharmaceutics 19 (3) (2022)
Morgane Denis, Chloé Grasselly, Pierre-Antoine Choffour, Anne Wierinckx, Doriane Mathé, Kamel Chettab, Anne Tourette, Nolan Talhi, Aurore Bourguignon, Fabian Birzele, Elsa Kress, Lars Petter Jordheim, Christiane Neumann, Eva-Laure Matera, Charles Dumontet
In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti-PD-1/PD-L1 Therapies. Cancer immunology research 10 (8) (2022)
Kamel Chettab, Jean-Louis Mestas, Maxime Lafond, Djamel Eddine Saadna, Cyril Lafon, Charles Dumontet
Doxorubicin Delivery into Tumor Cells by Stable Cavitation without Contrast Agents. Molecular pharmaceutics 14 (2) (2017)